Gapping down
In reaction to disappointing earnings/guidance: SNDK -11.9%, PSUN -4.2%, CMGE -3.5%, VRNT -2.8%, ASND -0.7%, OTIV -0.7%, LULU -0.5%, KITE -0.4%
Select Airline related names showing weakness: DAL -4.4%, LUV -3.3%, UAL -3.1%, ALK -3.1%, JBLU -2.6%
Select SNDK peers and semi names trading lower after SNDK released guidance: MU -4.1%, QRVO -3.8%, STM -3.3%, ARMH -3.3%, NXPI -3.1%, SWKS -2.5%, AMD -1.9%, EMC -1.1%, LLTC -1%
Other news: SCMP -12.8% ( announces a proposed underwritten public offering of shares of its class A common stock by selling stockholders), VG -11.8% (cont weakness), FF -10.1% (disclosed it received a notice from Procter & Gamble (PG) terminating a purchase agreement), NVAX -8.4% (announces it has priced an underwritten public offering of 24,137,931 shares of common stock at a price to the public of $7.25 per share), NLST -7.4% (confirms that a jury verdict has been reached in its case against Diablo Technologies in the United States District Court for the Northern District of California ), NBG -4.4% (cont vol in Greece), DPLO -4.1% (prices 8,540,109 shares of common stock at $29.00 per share; shares sold by co and selling shareholders), GTN -3% (prices 12 million shares of common stock at $13.00 per share), GWR -2.3% (entered into a $2.8 bln credit facility; co also lowered Q1 revenue guidance), CFG -0.9% (Royal Bank of Scotland (RBS) has agreed to sell 135 million shares of CFG's common stock at $23.75 per share)
Analyst comments: EXAS -5.5% (downgraded to Neutral from Buy at Goldman), ASML -3% (downgraded to Sell at Deutsche Bank), Q -2.5% (downgraded to Neutral from Buy at Sun Trust Rbsn Humphrey), COTY -2.5% (downgraded to Sell at B. Riley & Co), UBNT -2.3% (downgraded to Neutral from Outperform at Macquarie), NVO -1.2% (downgraded to Neutral at Bryan Garnier), NSC -1% (downgraded to Mkt Perform from Outperform at Raymond James), AEG -2.5% (downgraded to Hold from Buy at Deutsche Bank), UNP -1.6% (downgraded to Market Perform from Outperform at Cowen), MYGN -0.8% (downgraded to Neutral from Buy at Goldman
)
In reaction to disappointing earnings/guidance: SNDK -11.9%, PSUN -4.2%, CMGE -3.5%, VRNT -2.8%, ASND -0.7%, OTIV -0.7%, LULU -0.5%, KITE -0.4%
Select Airline related names showing weakness: DAL -4.4%, LUV -3.3%, UAL -3.1%, ALK -3.1%, JBLU -2.6%
Select SNDK peers and semi names trading lower after SNDK released guidance: MU -4.1%, QRVO -3.8%, STM -3.3%, ARMH -3.3%, NXPI -3.1%, SWKS -2.5%, AMD -1.9%, EMC -1.1%, LLTC -1%
Other news: SCMP -12.8% ( announces a proposed underwritten public offering of shares of its class A common stock by selling stockholders), VG -11.8% (cont weakness), FF -10.1% (disclosed it received a notice from Procter & Gamble (PG) terminating a purchase agreement), NVAX -8.4% (announces it has priced an underwritten public offering of 24,137,931 shares of common stock at a price to the public of $7.25 per share), NLST -7.4% (confirms that a jury verdict has been reached in its case against Diablo Technologies in the United States District Court for the Northern District of California ), NBG -4.4% (cont vol in Greece), DPLO -4.1% (prices 8,540,109 shares of common stock at $29.00 per share; shares sold by co and selling shareholders), GTN -3% (prices 12 million shares of common stock at $13.00 per share), GWR -2.3% (entered into a $2.8 bln credit facility; co also lowered Q1 revenue guidance), CFG -0.9% (Royal Bank of Scotland (RBS) has agreed to sell 135 million shares of CFG's common stock at $23.75 per share)
Analyst comments: EXAS -5.5% (downgraded to Neutral from Buy at Goldman), ASML -3% (downgraded to Sell at Deutsche Bank), Q -2.5% (downgraded to Neutral from Buy at Sun Trust Rbsn Humphrey), COTY -2.5% (downgraded to Sell at B. Riley & Co), UBNT -2.3% (downgraded to Neutral from Outperform at Macquarie), NVO -1.2% (downgraded to Neutral at Bryan Garnier), NSC -1% (downgraded to Mkt Perform from Outperform at Raymond James), AEG -2.5% (downgraded to Hold from Buy at Deutsche Bank), UNP -1.6% (downgraded to Market Perform from Outperform at Cowen), MYGN -0.8% (downgraded to Neutral from Buy at Goldman
)